Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2539 of 6351
-
Scientists hunt for kidney stone genes in 6,000-Person study
Knowledge-focused Recruiting nowThis study will attempt to identify the specific gene (coded in the DNA) and changes (mutations) within that gene that are the cause of monogenic kidney stone disease. This study will help researchers determine the characteristics of the stone disease associated with specific gen…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Tailored stents show promise for Hard-to-Treat aneurysms
Disease control CompletedIn this study patients will be observed, who receive a multi-branch stent graft tailored to the patients anatomy for the endovascular treatment of a thoracoabdominal aortic aneurysm Crawford type I, II, III, IV or V. The objective of this study is to evaluate clinical and techni…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New injection could ease arthritis pain
Symptom relief CompletedThe objective of this study is to verify the superiority of 16 weeks of MT-5547 treatment to placebo, as evidenced by the WOMAC pain score (the efficacy outcome measure), in patients with osteoarthritis of the knee or hip. Additional objectives of the study are to investigate the…
Phase 2/3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Border HIV prevention study targets drug users with community approach
Prevention CompletedThe proposed project is a research collaboration between the University of Texas at El Paso, The Alliance for Border Collaboratives in El Paso, Texas and Programa Companeros in Juarez City, Mexico to adapt, implement, and evaluate a multi-level community-based HIV prevention inte…
Sponsor: City University of New York • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Heart scan may predict who benefits from pacemaker therapy
Diagnosis CompletedThis study evaluates the state of the cardiac sympathetic activity and the severity of ventricular dyssynchrony in chronic heart failure patients and assesses the capabilities of radionuclide indication methods in determining the prognosis and evaluating the results of cardiac re…
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
New hip implant aims to stop joints from popping out after repeat surgery
Disease control Recruiting nowThe aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobi…
Phase 4 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a common bleeding drug cut transfusions after hip fractures?
Disease control OngoingTranexamic Acid (TXA) is an antifibrolytic medication used in total hip and knee arthroplasty to reduce the need for intraoperative and postoperative blood transfusions. Limited research is available on its use in hip fracture patients. We hypothesize that the use of TXA preopera…
Phase 4 • Sponsor: Gregory M Georgiadis MD • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New antidote for popular blood thinner shows promise in early trial
Disease control CompletedThis study is a randomized, single-blind, placebo-controlled study to assess the efficacy and safety of ciraparantag administered to healthy volunteers anticoagulated with apixaban measuring clotting times using Whole Blood Clotting Time (WBCT).
Phase 2 • Sponsor: Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 12:58 UTC
-
Cholera vaccine vaxchora put to the test in immune response study
Vaccine CompletedThe primary objective of this study is to evaluate the antibody response to the cholera vaccine, Vaxchora®, in healthy subjects. Investigators also seek to evaluate additional markers of the adaptive immune response including plasmablasts, activated B cells, memory B cells, and …
Phase 2 • Sponsor: Emory University • Aim: Vaccine
Last updated Jun 27, 2026 09:04 UTC
-
Shorter radiation blasts prostate tumors in early trial
Disease control CompletedThe purpose of the study is to find out the feasibility and effects of ultra-hypofractionated radiotherapy to the prostate and dominant lesion as definitive treatment for intermediate risk prostrate cancer.
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a special therapy keep young offenders out of trouble?
Disease control CompletedThis study's purpose is to examine the effectiveness of a promising intervention for emerging adults (EAs) with alcohol and other drug (AOD) abuse and justice involvement in achieving the ultimate outcome of reduced criminal activity. The study will also examine that effect on in…
Sponsor: Chestnut Health Systems • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New Eye-Tracking computer therapy could ease social anxiety
Symptom relief PausedThe present study is a double blind trial that seeks to examine the feasibility, acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy (GC-MRT) in individuals with social anxiety disorder (SAD)
Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New study tests Long-Term safety of schizophrenia drug in adolescents
Disease control CompletedTo further characterize the long-term safety and tolerability of brexpiprazole in adolescents with schizophrenia
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a simple biopsy replace major surgery after breast cancer chemo?
Knowledge-focused OngoingThis study is being done to help the investigators determine how accurate the sentinel lymph node biopsy (SLNB) procedure is in identifying residual cancer cells after neoadjuvant chemotherapy in patients presenting with locally advanced breast cancer.
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Pee power: urine test may spare kids painful kidney biopsies
Knowledge-focused CompletedThe objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Blood test could spare kids from risky food allergy challenges
Diagnosis CompletedBackground: The need for an oral food challenge (OFC) surrogate is growing in line with the continuous increase in the prevalence and severity of paediatric food allergy. The basophil activation test (BAT) has recently been reported as a promising tool for predicting the outcome …
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Radioactive beads show promise for liver tumors in french registry
Disease control CompletedSelective Internal Radiation Therapy (SIRT), also known as radioembolisation, is a minimal invasive, endovascular treatment for primary and secondary liver tumours. In France, SIR-Spheres are listed as reimbursable by the national health authorities (Haute Autorité de Santé \[HAS…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Harmonica breathing: a fun way to ease COPD symptoms?
Symptom relief Completed15 patients who have completed the Baylor Martha Foster Lung Center Pulmonary Rehabilitation Program at least six months ago will be selected to participate in a 12 week training program with six months of follow up.
Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could a cancer drug tame rare overgrowth disease?
Disease control Stopped earlySegmental overgrowth disorders are rare conditions characterised by abnormal growth which is usually asymmetric and confined to discrete parts of the body. We and others have identified mosaic activating mutations in the p110α catalytic subunit of phosphatidylinositol-3-kinase (P…
Phase 1/2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo drug aims to cut opioid use after hernia surgery
Symptom relief CompletedThis is a Phase 3, randomized, double-blind, saline placebo- and active-controlled, multicenter study to evaluate the analgesic efficacy and safety of HTX 011 administered via local administration into the surgical site in subjects undergoing unilateral open inguinal herniorrhaph…
Phase 3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC